Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 9—September 2015
THEME ISSUE
Emerging Infections Program

Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae

Nora Chea, Sandra N. Bulens, Thiphasone Kongphet-Tran, Ruth Lynfield, Kristin Shaw, Paula Snippes Vagnone, Marion Kainer, Daniel Muleta, Lucy Wilson, Elisabeth Vaeth, Ghinwa Dumyati, Cathleen Concannon, Erin C. Phipps, Karissa Culbreath, Sarah J. Janelle, Wendy Bamberg, Alice Y. Guh, Brandi M. Limbago, and Alexander J. KallenComments to Author 
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (N. Chea, S.N. Bulens, T. Kongphet-Tran, A.Y. Guh, B. Limbago, A.J. Kallen); Minnesota Department of Health, St. Paul, Minnesota, USA (R. Lynfield, K.M. Shaw, P. Snippes Vagnone); Tennessee Department of Health, Nashville, Tennessee, USA (M.A Kainer, D.B. Muleta); Maryland Emerging Infections Program, Baltimore, Maryland, USA (L. Wilson, E. Vaeth); New York–Rochester Emerging Infections Program, Rochester, New York, USA (G. Dumyati, C. Concannon); University of Rochester Medical Center, Rochester (G. Dumyati, C. Concannon); University of New Mexico, Albuquerque, New Mexico, USA (E.C. Phipps, K. Culbreath); Colorado Department of Public Health and Environment, Denver, Colorado, USA (S.J. Janelle, W.M. Bamberg)

Main Article

Table 3

False-positive and selected false-negative results in a study evaluating phenotype-based definitions for reliability in identifying carbapenemase producers among carbapenem-resistant enterobacterial isolates from 6 US Emerging Infections Program sites, January 1, 2011–January 30, 2014

Result No. isolates/no. tested (%), by definition no., N = 307*
1 2 3 4 5 6 7 8 9 10 11
False-positive 117/307 (38.1) 82/307 (26.7) 91/307 (29.6) 169/307 (55.0) 57/307 (18.6) 146/307 (47.6) 153/307 (49.8) 60/307 (19.5) 37/307 (12.1) 34/307 (11.1) 17/307 (5.5)
Selected false-negative 12/307 (3.9) 15/307 (4.9) 13/307 (4.2) 2/307 (0.7) 17/307 (5.5) 7/307 (2.3) 4/307 (1.3) 27/307 (8.8) 85/307 (27.7) 85/307 (27.7) 85/307 (27.7)

*False-positive isolates are those meeting the definition but not found to produce a carbapenemase. Selected false-negative isolates were selected on the basis of nonsuceptibility to >1 carbapenem not meeting the definition but found to produce a carbapenemase. Definitions: 1, nonsusceptible to any carbapenem, excluding ertapenem; 2, nonsusceptible to any carbapenem, excluding ertapenem, and resistant to all third-generation cephalosporins tested (pre-2015 Centers for Disease Control and Prevention carbapenem-resistant Enterobacteriaceae surveillance definition); 3, nonsusceptible to any carbapenem, excluding ertapenem, and resistant to any third-generation cephalosporins tested; 4, resistant to any carbapenem; 5, resistant to any carbapenem, excluding ertapenem; 6, resistant to any carbapenem and resistant to all third-generation cephalosporins tested; 7, resistant to any carbapenem and resistant to any third-generation cephalosporin tested; 8, nonsusceptible to at least 2 carbapenems (ertapenem resistant, if tested); 9, nonsusceptible to any carbapenem (ertapenem resistant, if tested) and resistant to cefepime; 10, resistant to any carbapenem and resistant to cefepime; and 11, nonsusceptible to any carbapenem, excluding ertapenem, and resistant to cefepime.

Main Article

Page created: August 12, 2015
Page updated: August 12, 2015
Page reviewed: August 12, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external